As of 10:30:56 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,581,500.00
1,581,600.00
1,284,700.00
1,499,200.00
1,204,500.00
Investing Cash Flow
-817,700.00
-778,900.00
-529,200.00
-503,600.00
-613,800.00
Financing Cash Flow
-495,300.00
-763,500.00
-843,800.00
-1,306,000.00
-421,800.00
End Cash Position
560,600.00
415,800.00
375,700.00
478,500.00
802,100.00
Capital Expenditure
-322,700.00
-377,500.00
-187,900.00
-152,000.00
-111,900.00
Issuance of Debt
1,199,800.00
499,800.00
83,000.00
1,599,800.00
1,497,100.00
Repayment of Debt
-30,000.00
-120,200.00
-1,518,700.00
-2,654,800.00
-1,750,000.00
Repurchase of Capital Stock
-1,206,100.00
-692,200.00
-126,400.00
--
--
Free Cash Flow
1,258,800.00
1,204,100.00
1,096,800.00
1,347,200.00
1,092,600.00
12/31/2020 - 7/25/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ZIMV ZimVie Inc.
14.35
+0.49%
SYK Stryker Corporation
376.12
-0.01%
MDT Medtronic plc
83.02
+0.12%
SNN Smith & Nephew plc
25.61
-0.58%
GMED Globus Medical, Inc.
83.43
+0.59%
CNMD CONMED Corporation
74.33
+1.38%
BSX Boston Scientific Corporation
91.29
+0.80%
STE STERIS plc
211.17
+0.74%
IART Integra LifeSciences Holdings Corporation
24.10
-0.23%
BIO Bio-Rad Laboratories, Inc.
338.01
-1.02%